These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31622332)

  • 1. Surfactant delivery in rat lungs: Comparing 3D geometrical simulation model with experimental instillation.
    Kazemi A; Louis B; Isabey D; Nieman GF; Gatto LA; Satalin J; Baker S; Grotberg JB; Filoche M
    PLoS Comput Biol; 2019 Oct; 15(10):e1007408. PubMed ID: 31622332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional model of surfactant replacement therapy.
    Filoche M; Tai CF; Grotberg JB
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9287-92. PubMed ID: 26170310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of selective wedge instillation of pulmonary surfactant for COVID-19 pneumonia based on computational fluid dynamics simulation.
    Kitaoka H; Kobayashi H; Takimoto T; Kijima T
    BMC Pulm Med; 2021 Feb; 21(1):62. PubMed ID: 33618696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracheal acid or surfactant instillation raises alveolar surface tension.
    Nguyen TL; Perlman CE
    J Appl Physiol (1985); 2018 Nov; 125(5):1357-1367. PubMed ID: 29771610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quantitative Study of Transport of Surfactant Boli in a Three-Dimensional Lung Model of Neonates.
    Combs H; Shark T; Heiss J; Raessi M; Tavana H
    J Biomech Eng; 2023 Feb; 145(2):. PubMed ID: 36056568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
    Häfner D; Germann PG
    J Pharmacol Toxicol Methods; 1999; 41(2-3):97-106. PubMed ID: 10598681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Three-Dimensional Model of Human Lung Airway Tree to Study Therapeutics Delivery in the Lungs.
    Copploe A; Vatani M; Choi JW; Tavana H
    Ann Biomed Eng; 2019 Jun; 47(6):1435-1445. PubMed ID: 30859435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS).
    Gommers D; Eijking EP; So KL; van't Veen A; Lachmann B
    Intensive Care Med; 1998 May; 24(5):494-500. PubMed ID: 9660267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural surfactant instilled in premature lambs increases lung volume and improves ventilation homogeneity within five minutes.
    Vilstrup C; Gommers D; Bos JA; Lachmann B; Werner O; Larsson A
    Pediatr Res; 1992 Nov; 32(5):595-9. PubMed ID: 1480463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Techniques to evaluate surfactant activity for a personalized therapy of RDS neonates.
    Autilio C
    Biomed J; 2021 Dec; 44(6):671-677. PubMed ID: 34758409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
    Häfner D; Ibrahim M; Wollin L; Germann PG
    Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant replacement therapy.
    Stevens TP; Sinkin RA
    Chest; 2007 May; 131(5):1577-82. PubMed ID: 17494810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
    Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
    Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.
    Sankar MJ; Gupta N; Jain K; Agarwal R; Paul VK
    J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S36-48. PubMed ID: 27109091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Bahadue FL; Soll R
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rat lung model of instilled liquid transport in the pulmonary airways.
    Cassidy KJ; Bull JL; Glucksberg MR; Dawson CA; Haworth ST; Hirschl R; Gavriely N; Grotberg JB
    J Appl Physiol (1985); 2001 May; 90(5):1955-67. PubMed ID: 11299290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of exogenous surfactant in neonates with respiratory distress syndrome.
    Hallman M; Merritt TA; Bry K
    Clin Pharmacokinet; 1994 Mar; 26(3):215-32. PubMed ID: 8194284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic surfactant with a combined SP-B and SP-C analogue is efficient in rabbit models of adult and neonatal respiratory distress syndrome.
    Mikolka P; Kronqvist N; Haegerstrand-Björkman M; Jaudzems K; Kosutova P; Kolomaznik M; Saluri M; Landreh M; Calkovska A; Curstedt T; Johansson J
    Transl Res; 2023 Dec; 262():60-74. PubMed ID: 37499744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.
    Gortner L
    J Perinat Med; 1992; 20(6):409-19. PubMed ID: 1293266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.